The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...
In a recent study, researchers conducted ... Immune Cell Regulator Discovery Could Lead to Treatments for Arthritis and Severe COVID Aug. 14, 2024 — The discovery of a new regulator affecting ...